GHRS
GHRS
NASDAQ · Pharmaceuticals

Gh Research Plc

$14.00
+0.61 (+4.56%)
As of Mar 25, 2:15 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +244.5% upside
Low Target $34.28
Average Target $48.23
High Target $66.93
Current Price $14.00
Current
$14.00
Target
$48.23
$34.28 $48.23 avg $66.93
Scenario Analysis
Bear Case
$34.28
144.9%
Low target
Base Case
$48.23
+244.5%
Avg target
Bull Case
$66.93
+378.1%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$19.51
-28.2% from high
52-Week Low
$7.98
+75.4% from low
Target vs 52W High
$48.23
+147.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%